Sergio Garcia-Fernandez
Overview
Explore the profile of Sergio Garcia-Fernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lara I, Hernandez-Ruiz V, Fernandez-Huerta M, Rodriguez-Grande J, Arnaiz De Las Revillas F, Rodriguez-Lozano J, et al.
Sex Transm Infect
. 2025 Mar;
PMID: 40081911
Objectives: (MG) STIs represent a global concern, especially considering its rapid ability to acquire antimicrobial resistance. The objective of this study was to investigate the epidemiology of MG and antibiotic...
2.
Garcia-Fernandez S, Rodriguez-Grande J, Siller-Ruiz M, Fraile-Valcarcel N, Lara-Plaza I, Moure Z, et al.
Int J Antimicrob Agents
. 2024 Jun;
64(2):107257.
PMID: 38914141
Objectives: To describe the in vivo emergence of ceftazidime-avibactam resistance in GES-type carbapenemases and to characterize an unusual outbreak of GES-6-producing Serratia marcescens during the COVID-19 pandemic in Spain. Methods:...
3.
Rodriguez-Villodres A, Lepe-Balsalobre E, Ortiz de la Rosa J, Giner Almaraz S, Gonzalez de Herrero E, Cercenado E, et al.
JAC Antimicrob Resist
. 2024 Jun;
6(3):dlae087.
PMID: 38847006
Objectives: To analyse the susceptibility profile to cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations in complex and isolated from intra-abdominal, urinary, respiratory and bloodstream infections in the SMART (Study for...
4.
Ortiz-Cartagena C, Pablo-Marcos D, Fernandez-Garcia L, Blasco L, Pacios O, Bleriot I, et al.
Microbiol Spectr
. 2023 Jul;
11(4):e0132923.
PMID: 37466441
Carbapenem-resistant pathogens have been recognized as a health concern as they are both difficult to treat and detect in clinical microbiology laboratories. Researchers are making great efforts to develop highly...
5.
Garcia-Fernandez S, Pablo-Marcos D, Velasco de la Fuente S, Rodriguez M, Gozalo M, Rodriguez-Lozano J, et al.
Diagn Microbiol Infect Dis
. 2022 Apr;
103(2):115683.
PMID: 35421760
The purpose of this study was to assess the clinical performance of STANDARD F COVID-19 Ag FIA (SD Biosensor Inc., Gyeonggi-do, Republic of Korea), a rapid antigen detection test (RADT)...
6.
Garcia-Fernandez S, Simner P, Thomson G, Faron M, Bosboom R, van Griethuijsen A, et al.
Diagn Microbiol Infect Dis
. 2021 Oct;
102(1):115554.
PMID: 34678712
We conducted an international multicentre evaluation to assess the clinical performance characteristics of the new multiplex PCR-based BD MAX Check-Points CPO assay to detect the 5 major carbapenemase families: KPC,...
7.
Hernandez-Garcia M, Garcia-Fernandez S, Garcia-Castillo M, Passaro L, Canton R
FEMS Microbiol Lett
. 2021 Aug;
368(15).
PMID: 34347078
Purpose: to characterize the distribution and mechanisms involved in ceftolozane/tazobactam (C/T) resistance in Pseudomonas aeruginosa isolates recovered from intensive care units (ICUs) in Portugal as part of the STEP surveillance...
8.
Hernandez-Garcia M, Garcia-Fernandez S, Garcia-Castillo M, Bou G, Cercenado E, Delgado-Valverde M, et al.
JAC Antimicrob Resist
. 2021 Jul;
2(4):dlaa084.
PMID: 34223039
Objectives: To analyse by WGS the ceftolozane/tazobactam (C/T) resistance mechanisms in and spp. isolates recovered from complicated intra-abdominal and urinary tract infections in patients from Spanish ICUs (SUPERIOR surveillance study,...
9.
Suarez-Carantona C, Rodriguez-Torres A, Viteri-Noel A, Pintado V, Garcia-Fernandez S, Mora-Pimentel D, et al.
J Clin Med
. 2021 Apr;
10(8).
PMID: 33921309
The availability of highly sensitive molecular tests for the detection of in feces leads to overtreatment of patients who are probably only colonized. In this prospective study, the usefulness of...
10.
Hernandez-Garcia M, Garcia-Castillo M, Garcia-Fernandez S, Lopez-Mendoza D, Diaz-Reganon J, Romano J, et al.
Microorganisms
. 2021 Mar;
9(2).
PMID: 33672870
CrpP enzymes have been recently described as a novel ciprofloxacin-resistance mechanism. We investigated by whole genome sequencing the presence of -genes and other mechanisms involved in quinolone resistance in MDR/XDR-...